NEWS DETAIL

处方药用户收费法案、生物类似药用户收费法案及仿制药用户收费修正案的财务透明度和效率 – 2026年6月23日

.gov 表示它是官方网站。联邦政府网站通常以 .gov 或 .mil 结尾。在分享敏感信息之前,请确保您访问的是联邦政府网站。该网站是安全的。

医药资讯

正文内容

News & Events for Human Drugs Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments – 06/23/2026 The Food and Drug Administration (FDA or the Agency) is announcing its annual public meeting and opportunity for public comment on “Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments”. This public meeting is intended to meet performance commitments included in PDUFA VII, BsUFA III, and GDUFA III. These user fee programs were reauthorized as part of the FDA User Fee Reauthorization Act of 2022 signed by the President on September 30,2022. The complete set of performance goals for each program are available at: This meeting will provide FDA the opportunity to update interested public stakeholders on topics related to the financial management of PDUFA VII, BsUFA III, and GDUFA III. This year, FDA will present the 5-year financial plans for each of these programs and update participants on the progress towards implementing resource capacity planning as part of fee setting and modernized time reporting. The Federal Register Notice announcing the meeting can be found here. Please register to attend the event via Teams. If you need special accommodations, please indicate this during registration or contact the Business Management Services (BMS) team at OFBABusinessManagementServices@fda. hhs. gov by June 20,2026, at 11: 59 PM Eastern Time. 2025 MaterialsAgendaMeeting TranscriptRecording / Transcript 2024 MaterialsAgendaPresentationRecording / Transcript 2023 MaterialsAgendaPresentationRecording/Transcript 2022 MaterialsAgendaPresentationMeeting RecordingAudio Transcript 2021 Materials2021 Agenda2021 Presentation2021 Webcast Recording – Passcode: &7UNVA%82021 Transcript 2021 Webcast Recording – Passcode: &7UNVA%8 10903 New Hampshire Avenue Building 31, Room 1503 Silver Spring, MD 20993 United States

常见问题

这篇文章和哪些产品相关?

目前没有匹配到足够强相关的商品,补充正文或新增产品后会自动重新关联。

阅读《处方药用户收费法案、生物类似药用户收费法案及仿制药用户收费修正案的财务透明度和效率 - 2026年6月23日》后,如何查看对应药品?

点击文章下方的相关商品卡片,即可查看商品规格、价格、说明和评价。

本文内容可以替代医生或药师建议吗?

不能。本文只提供一般药品信息和健康教育,具体用药应遵循医生处方和药师指导。

WhatsApp WhatsApp 微信 微信